KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

GoodRx Holdings (GDRX) Other Non Operating Income (2019 - 2025)

GoodRx Holdings' Other Non Operating Income history spans 5 years, with the latest figure at $718000.0 for Q4 2025.

  • On a quarterly basis, Other Non Operating Income fell 84.72% to $718000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $6.1 million, a 133.02% increase, with the full-year FY2025 number at $718000.0, up 134.57% from a year prior.
  • Other Non Operating Income hit $718000.0 in Q4 2025 for GoodRx Holdings, up from $694000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for GDRX hit a ceiling of $4.7 million in Q4 2024 and a floor of -$4.0 million in Q4 2023.
  • Historically, Other Non Operating Income has averaged -$296833.3 across 3 years, with a median of -$557000.0 in 2023.
  • Biggest five-year swings in Other Non Operating Income: surged 217.27% in 2024 and later crashed 84.72% in 2025.
  • Tracing GDRX's Other Non Operating Income over 3 years: stood at -$4.0 million in 2023, then surged by 217.27% to $4.7 million in 2024, then crashed by 84.72% to $718000.0 in 2025.
  • Business Quant data shows Other Non Operating Income for GDRX at $718000.0 in Q4 2025, $694000.0 in Q2 2025, and $4.7 million in Q4 2024.